Rolf A. Brekken
Impact in
- Cancer Research top 0.1%
- Cancer, Hypoxia, and Metabolism
- Oncology top 0.2%
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
Papers in
-
- Angiogenesis and VEGF in Cancer 53
- Oncology 98
- Pancreatic and Hepatic Oncology Research 48
- Cancer Cells and Metastasis 18
- Co-authors
- E. Helene Sage (14 shared papers)Philip E. Thorpe (17 shared papers)Anirban Maitra (6 shared papers)Abdel Hosein (4 shared papers)Seán Dineen (14 shared papers)Gabriele Bergers (2 shared papers)Thiennu H. Vu (1 shared paper)Zena Werb (1 shared paper)
- Journals
- Cancer Research (26 papers)Journal of Clinical Oncology (10 papers)Journal of Clinical Investigation (9 papers)PLoS ONE (8 papers)Molecular Cancer Research (7 papers)
- Partner nations
- United StatesNorwayUnited Kingdom
In The Last Decade
Rolf A. Brekken
268 papers receiving 19.5k citations
Rolf A. Brekken's Hit Papers
Peers
Comparison fields: 5 of 151
- Cancer Research 3.9k
- Oncology 5.6k
- Immunology and Allergy 1.1k
- Immunology 3.3k
- Molecular Biology 8.4k
Countries citing papers authored by Rolf A. Brekken
This map shows the geographic impact of Rolf A. Brekken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rolf A. Brekken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rolf A. Brekken more than expected).
Fields of papers citing papers by Rolf A. Brekken
This network shows the impact of papers produced by Rolf A. Brekken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rolf A. Brekken. The network helps show where Rolf A. Brekken may publish in the future.
Co-authors
The 25 scholars most cited alongside Rolf A. Brekken, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 275 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis Hit paper breakdown → | 2000 | 2230 |
| 2 | Hypoxia-Inducible Factor 1α Induces Fibrosis and Insulin Resistance in White Adipose Tissue Hit paper breakdown → | 2009 | 700 |
| 3 | Pancreatic cancer stroma: an update on therapeutic targeting strategies Hit paper breakdown → | 2020 | 668 |
| 4 | Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer Hit paper breakdown → | 2016 | 552 |
| 5 | 2001 | 490 | |
| 6 | Mesothelial cell-derived antigen-presenting cancer-associated fibroblasts induce expansion of regulatory T cells in pancreatic cancer Hit paper breakdown → | 2022 | 357 |
| 7 | 2012 | 332 | |
| 8 | 2003 | 311 | |
| 9 | 2013 | 291 | |
| 10 | Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice. | 2000 | 269 |
| 11 | 2002 | 264 | |
| 12 | 2000 | 254 | |
| 13 | 2018 | 248 | |
| 14 | 2013 | 235 | |
| 15 | 2007 | 233 | |
| 16 | 2010 | 205 | |
| 17 | 2014 | 199 | |
| 18 | 2019 | 199 | |
| 19 | 2008 | 198 | |
| 20 | 2007 | 197 |
About Rolf A. Brekken
Rolf A. Brekken is a scholar working on Molecular Biology, Oncology, Immunology, Cancer Research and Rheumatology, having authored 275 papers that have together received 19.8k indexed citations. Recurring topics across this work include Phagocytosis and Immune Regulation (55 papers), Angiogenesis and VEGF in Cancer (53 papers), Pancreatic and Hepatic Oncology Research (48 papers), Cancer, Hypoxia, and Metabolism (30 papers), Bone and Dental Protein Studies (30 papers), Cell Adhesion Molecules Research (29 papers), Immune cells in cancer (28 papers) and Cancer Cells and Metastasis (18 papers). The work is most often cited by research in Cancer Research (3.9k citations), Oncology (5.6k citations), Immunology and Allergy (1.1k citations), Immunology (3.3k citations) and Molecular Biology (8.4k citations). Rolf A. Brekken has collaborated with scholars based in United States, Norway and United Kingdom. Frequent co-authors include E. Helene Sage, Philip E. Thorpe, Anirban Maitra, Abdel Hosein, Seán Dineen, Gabriele Bergers, Thiennu H. Vu, Zena Werb, Kazuhiko Tanzawa and Kazuhiko Tamaki. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Journal of Clinical Investigation, PLoS ONE and Molecular Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.